Global Gabapentin Drug Market Growth 2025-2031
The global Gabapentin Drug market size is predicted to grow from US$ 1674 million in 2025 to US$ 2086 million in 2031; it is expected to grow at a CAGR of 3.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Gabapentin Drug Industry Forecast? looks at past sales and reviews total world Gabapentin Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Gabapentin Drug sales for 2025 through 2031. With Gabapentin Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gabapentin Drug industry.
This Insight Report provides a comprehensive analysis of the global Gabapentin Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gabapentin Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Gabapentin Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gabapentin Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gabapentin Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Gabapentin Drug market?
What factors are driving Gabapentin Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gabapentin Drug market opportunities vary by end market size?
How does Gabapentin Drug break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Gabapentin Drug Industry Forecast? looks at past sales and reviews total world Gabapentin Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Gabapentin Drug sales for 2025 through 2031. With Gabapentin Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gabapentin Drug industry.
This Insight Report provides a comprehensive analysis of the global Gabapentin Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gabapentin Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Gabapentin Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gabapentin Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gabapentin Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Capsule
- Tablet
- Oral Solution
- Postherpetic Neuralgia in Adults
- Partial Onset Seizures
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Depomed
- Apotex
- Teva
- Acella Pharmaceuticals
- Taro
- Sun Pharmaceutical
- Glenmark
- Amneal Pharmaceuticals
- Aurobindo Pharma
- Zydus Pharmaceuticals
- Hi-Tech Pharmaceuticals
- Marksans Pharma
- Mylan
- InvaGen Pharmaceuticals
- Alkem Laboratories
- Tris Pharma
- ACI HealthCare Limited
- Jiangsu Hengrui Medicine
- CSPC Ouyi Pharmaceutical
- Sciegen Pharmaceuticals
- Epic Pharma
- Lupin Limited
What is the 10-year outlook for the global Gabapentin Drug market?
What factors are driving Gabapentin Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gabapentin Drug market opportunities vary by end market size?
How does Gabapentin Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gabapentin Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Gabapentin Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Gabapentin Drug by Country/Region, 2020, 2024 & 2031
2.2 Gabapentin Drug Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.2.3 Oral Solution
2.3 Gabapentin Drug Sales by Type
2.3.1 Global Gabapentin Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Gabapentin Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Gabapentin Drug Sale Price by Type (2020-2025)
2.4 Gabapentin Drug Segment by Application
2.4.1 Postherpetic Neuralgia in Adults
2.4.2 Partial Onset Seizures
2.4.3 Others
2.5 Gabapentin Drug Sales by Application
2.5.1 Global Gabapentin Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Gabapentin Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Gabapentin Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Gabapentin Drug Breakdown Data by Company
3.1.1 Global Gabapentin Drug Annual Sales by Company (2020-2025)
3.1.2 Global Gabapentin Drug Sales Market Share by Company (2020-2025)
3.2 Global Gabapentin Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Gabapentin Drug Revenue by Company (2020-2025)
3.2.2 Global Gabapentin Drug Revenue Market Share by Company (2020-2025)
3.3 Global Gabapentin Drug Sale Price by Company
3.4 Key Manufacturers Gabapentin Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gabapentin Drug Product Location Distribution
3.4.2 Players Gabapentin Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GABAPENTIN DRUG BY GEOGRAPHIC REGION
4.1 World Historic Gabapentin Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Gabapentin Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Gabapentin Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Gabapentin Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Gabapentin Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Gabapentin Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gabapentin Drug Sales Growth
4.4 APAC Gabapentin Drug Sales Growth
4.5 Europe Gabapentin Drug Sales Growth
4.6 Middle East & Africa Gabapentin Drug Sales Growth
5 AMERICAS
5.1 Americas Gabapentin Drug Sales by Country
5.1.1 Americas Gabapentin Drug Sales by Country (2020-2025)
5.1.2 Americas Gabapentin Drug Revenue by Country (2020-2025)
5.2 Americas Gabapentin Drug Sales by Type (2020-2025)
5.3 Americas Gabapentin Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gabapentin Drug Sales by Region
6.1.1 APAC Gabapentin Drug Sales by Region (2020-2025)
6.1.2 APAC Gabapentin Drug Revenue by Region (2020-2025)
6.2 APAC Gabapentin Drug Sales by Type (2020-2025)
6.3 APAC Gabapentin Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gabapentin Drug by Country
7.1.1 Europe Gabapentin Drug Sales by Country (2020-2025)
7.1.2 Europe Gabapentin Drug Revenue by Country (2020-2025)
7.2 Europe Gabapentin Drug Sales by Type (2020-2025)
7.3 Europe Gabapentin Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gabapentin Drug by Country
8.1.1 Middle East & Africa Gabapentin Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Gabapentin Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Gabapentin Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Gabapentin Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gabapentin Drug
10.3 Manufacturing Process Analysis of Gabapentin Drug
10.4 Industry Chain Structure of Gabapentin Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gabapentin Drug Distributors
11.3 Gabapentin Drug Customer
12 WORLD FORECAST REVIEW FOR GABAPENTIN DRUG BY GEOGRAPHIC REGION
12.1 Global Gabapentin Drug Market Size Forecast by Region
12.1.1 Global Gabapentin Drug Forecast by Region (2026-2031)
12.1.2 Global Gabapentin Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Gabapentin Drug Forecast by Type (2026-2031)
12.7 Global Gabapentin Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Gabapentin Drug Product Portfolios and Specifications
13.1.3 Pfizer Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Depomed
13.2.1 Depomed Company Information
13.2.2 Depomed Gabapentin Drug Product Portfolios and Specifications
13.2.3 Depomed Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Depomed Main Business Overview
13.2.5 Depomed Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Gabapentin Drug Product Portfolios and Specifications
13.3.3 Apotex Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Gabapentin Drug Product Portfolios and Specifications
13.4.3 Teva Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Acella Pharmaceuticals
13.5.1 Acella Pharmaceuticals Company Information
13.5.2 Acella Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Acella Pharmaceuticals Main Business Overview
13.5.5 Acella Pharmaceuticals Latest Developments
13.6 Taro
13.6.1 Taro Company Information
13.6.2 Taro Gabapentin Drug Product Portfolios and Specifications
13.6.3 Taro Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Taro Main Business Overview
13.6.5 Taro Latest Developments
13.7 Sun Pharmaceutical
13.7.1 Sun Pharmaceutical Company Information
13.7.2 Sun Pharmaceutical Gabapentin Drug Product Portfolios and Specifications
13.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sun Pharmaceutical Main Business Overview
13.7.5 Sun Pharmaceutical Latest Developments
13.8 Glenmark
13.8.1 Glenmark Company Information
13.8.2 Glenmark Gabapentin Drug Product Portfolios and Specifications
13.8.3 Glenmark Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Glenmark Main Business Overview
13.8.5 Glenmark Latest Developments
13.9 Amneal Pharmaceuticals
13.9.1 Amneal Pharmaceuticals Company Information
13.9.2 Amneal Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Amneal Pharmaceuticals Main Business Overview
13.9.5 Amneal Pharmaceuticals Latest Developments
13.10 Aurobindo Pharma
13.10.1 Aurobindo Pharma Company Information
13.10.2 Aurobindo Pharma Gabapentin Drug Product Portfolios and Specifications
13.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Aurobindo Pharma Main Business Overview
13.10.5 Aurobindo Pharma Latest Developments
13.11 Zydus Pharmaceuticals
13.11.1 Zydus Pharmaceuticals Company Information
13.11.2 Zydus Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Zydus Pharmaceuticals Main Business Overview
13.11.5 Zydus Pharmaceuticals Latest Developments
13.12 Hi-Tech Pharmaceuticals
13.12.1 Hi-Tech Pharmaceuticals Company Information
13.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hi-Tech Pharmaceuticals Main Business Overview
13.12.5 Hi-Tech Pharmaceuticals Latest Developments
13.13 Marksans Pharma
13.13.1 Marksans Pharma Company Information
13.13.2 Marksans Pharma Gabapentin Drug Product Portfolios and Specifications
13.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Marksans Pharma Main Business Overview
13.13.5 Marksans Pharma Latest Developments
13.14 Mylan
13.14.1 Mylan Company Information
13.14.2 Mylan Gabapentin Drug Product Portfolios and Specifications
13.14.3 Mylan Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Mylan Main Business Overview
13.14.5 Mylan Latest Developments
13.15 InvaGen Pharmaceuticals
13.15.1 InvaGen Pharmaceuticals Company Information
13.15.2 InvaGen Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 InvaGen Pharmaceuticals Main Business Overview
13.15.5 InvaGen Pharmaceuticals Latest Developments
13.16 Alkem Laboratories
13.16.1 Alkem Laboratories Company Information
13.16.2 Alkem Laboratories Gabapentin Drug Product Portfolios and Specifications
13.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Alkem Laboratories Main Business Overview
13.16.5 Alkem Laboratories Latest Developments
13.17 Tris Pharma
13.17.1 Tris Pharma Company Information
13.17.2 Tris Pharma Gabapentin Drug Product Portfolios and Specifications
13.17.3 Tris Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Tris Pharma Main Business Overview
13.17.5 Tris Pharma Latest Developments
13.18 ACI HealthCare Limited
13.18.1 ACI HealthCare Limited Company Information
13.18.2 ACI HealthCare Limited Gabapentin Drug Product Portfolios and Specifications
13.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 ACI HealthCare Limited Main Business Overview
13.18.5 ACI HealthCare Limited Latest Developments
13.19 Jiangsu Hengrui Medicine
13.19.1 Jiangsu Hengrui Medicine Company Information
13.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolios and Specifications
13.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Jiangsu Hengrui Medicine Main Business Overview
13.19.5 Jiangsu Hengrui Medicine Latest Developments
13.20 CSPC Ouyi Pharmaceutical
13.20.1 CSPC Ouyi Pharmaceutical Company Information
13.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolios and Specifications
13.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 CSPC Ouyi Pharmaceutical Main Business Overview
13.20.5 CSPC Ouyi Pharmaceutical Latest Developments
13.21 Sciegen Pharmaceuticals
13.21.1 Sciegen Pharmaceuticals Company Information
13.21.2 Sciegen Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Sciegen Pharmaceuticals Main Business Overview
13.21.5 Sciegen Pharmaceuticals Latest Developments
13.22 Epic Pharma
13.22.1 Epic Pharma Company Information
13.22.2 Epic Pharma Gabapentin Drug Product Portfolios and Specifications
13.22.3 Epic Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Epic Pharma Main Business Overview
13.22.5 Epic Pharma Latest Developments
13.23 Lupin Limited
13.23.1 Lupin Limited Company Information
13.23.2 Lupin Limited Gabapentin Drug Product Portfolios and Specifications
13.23.3 Lupin Limited Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Lupin Limited Main Business Overview
13.23.5 Lupin Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gabapentin Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Gabapentin Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Gabapentin Drug by Country/Region, 2020, 2024 & 2031
2.2 Gabapentin Drug Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.2.3 Oral Solution
2.3 Gabapentin Drug Sales by Type
2.3.1 Global Gabapentin Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Gabapentin Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Gabapentin Drug Sale Price by Type (2020-2025)
2.4 Gabapentin Drug Segment by Application
2.4.1 Postherpetic Neuralgia in Adults
2.4.2 Partial Onset Seizures
2.4.3 Others
2.5 Gabapentin Drug Sales by Application
2.5.1 Global Gabapentin Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Gabapentin Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Gabapentin Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Gabapentin Drug Breakdown Data by Company
3.1.1 Global Gabapentin Drug Annual Sales by Company (2020-2025)
3.1.2 Global Gabapentin Drug Sales Market Share by Company (2020-2025)
3.2 Global Gabapentin Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Gabapentin Drug Revenue by Company (2020-2025)
3.2.2 Global Gabapentin Drug Revenue Market Share by Company (2020-2025)
3.3 Global Gabapentin Drug Sale Price by Company
3.4 Key Manufacturers Gabapentin Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gabapentin Drug Product Location Distribution
3.4.2 Players Gabapentin Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GABAPENTIN DRUG BY GEOGRAPHIC REGION
4.1 World Historic Gabapentin Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Gabapentin Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Gabapentin Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Gabapentin Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Gabapentin Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Gabapentin Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gabapentin Drug Sales Growth
4.4 APAC Gabapentin Drug Sales Growth
4.5 Europe Gabapentin Drug Sales Growth
4.6 Middle East & Africa Gabapentin Drug Sales Growth
5 AMERICAS
5.1 Americas Gabapentin Drug Sales by Country
5.1.1 Americas Gabapentin Drug Sales by Country (2020-2025)
5.1.2 Americas Gabapentin Drug Revenue by Country (2020-2025)
5.2 Americas Gabapentin Drug Sales by Type (2020-2025)
5.3 Americas Gabapentin Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gabapentin Drug Sales by Region
6.1.1 APAC Gabapentin Drug Sales by Region (2020-2025)
6.1.2 APAC Gabapentin Drug Revenue by Region (2020-2025)
6.2 APAC Gabapentin Drug Sales by Type (2020-2025)
6.3 APAC Gabapentin Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gabapentin Drug by Country
7.1.1 Europe Gabapentin Drug Sales by Country (2020-2025)
7.1.2 Europe Gabapentin Drug Revenue by Country (2020-2025)
7.2 Europe Gabapentin Drug Sales by Type (2020-2025)
7.3 Europe Gabapentin Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gabapentin Drug by Country
8.1.1 Middle East & Africa Gabapentin Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Gabapentin Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Gabapentin Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Gabapentin Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gabapentin Drug
10.3 Manufacturing Process Analysis of Gabapentin Drug
10.4 Industry Chain Structure of Gabapentin Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gabapentin Drug Distributors
11.3 Gabapentin Drug Customer
12 WORLD FORECAST REVIEW FOR GABAPENTIN DRUG BY GEOGRAPHIC REGION
12.1 Global Gabapentin Drug Market Size Forecast by Region
12.1.1 Global Gabapentin Drug Forecast by Region (2026-2031)
12.1.2 Global Gabapentin Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Gabapentin Drug Forecast by Type (2026-2031)
12.7 Global Gabapentin Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Gabapentin Drug Product Portfolios and Specifications
13.1.3 Pfizer Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Depomed
13.2.1 Depomed Company Information
13.2.2 Depomed Gabapentin Drug Product Portfolios and Specifications
13.2.3 Depomed Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Depomed Main Business Overview
13.2.5 Depomed Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Gabapentin Drug Product Portfolios and Specifications
13.3.3 Apotex Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Gabapentin Drug Product Portfolios and Specifications
13.4.3 Teva Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Acella Pharmaceuticals
13.5.1 Acella Pharmaceuticals Company Information
13.5.2 Acella Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Acella Pharmaceuticals Main Business Overview
13.5.5 Acella Pharmaceuticals Latest Developments
13.6 Taro
13.6.1 Taro Company Information
13.6.2 Taro Gabapentin Drug Product Portfolios and Specifications
13.6.3 Taro Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Taro Main Business Overview
13.6.5 Taro Latest Developments
13.7 Sun Pharmaceutical
13.7.1 Sun Pharmaceutical Company Information
13.7.2 Sun Pharmaceutical Gabapentin Drug Product Portfolios and Specifications
13.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sun Pharmaceutical Main Business Overview
13.7.5 Sun Pharmaceutical Latest Developments
13.8 Glenmark
13.8.1 Glenmark Company Information
13.8.2 Glenmark Gabapentin Drug Product Portfolios and Specifications
13.8.3 Glenmark Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Glenmark Main Business Overview
13.8.5 Glenmark Latest Developments
13.9 Amneal Pharmaceuticals
13.9.1 Amneal Pharmaceuticals Company Information
13.9.2 Amneal Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Amneal Pharmaceuticals Main Business Overview
13.9.5 Amneal Pharmaceuticals Latest Developments
13.10 Aurobindo Pharma
13.10.1 Aurobindo Pharma Company Information
13.10.2 Aurobindo Pharma Gabapentin Drug Product Portfolios and Specifications
13.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Aurobindo Pharma Main Business Overview
13.10.5 Aurobindo Pharma Latest Developments
13.11 Zydus Pharmaceuticals
13.11.1 Zydus Pharmaceuticals Company Information
13.11.2 Zydus Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Zydus Pharmaceuticals Main Business Overview
13.11.5 Zydus Pharmaceuticals Latest Developments
13.12 Hi-Tech Pharmaceuticals
13.12.1 Hi-Tech Pharmaceuticals Company Information
13.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hi-Tech Pharmaceuticals Main Business Overview
13.12.5 Hi-Tech Pharmaceuticals Latest Developments
13.13 Marksans Pharma
13.13.1 Marksans Pharma Company Information
13.13.2 Marksans Pharma Gabapentin Drug Product Portfolios and Specifications
13.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Marksans Pharma Main Business Overview
13.13.5 Marksans Pharma Latest Developments
13.14 Mylan
13.14.1 Mylan Company Information
13.14.2 Mylan Gabapentin Drug Product Portfolios and Specifications
13.14.3 Mylan Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Mylan Main Business Overview
13.14.5 Mylan Latest Developments
13.15 InvaGen Pharmaceuticals
13.15.1 InvaGen Pharmaceuticals Company Information
13.15.2 InvaGen Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 InvaGen Pharmaceuticals Main Business Overview
13.15.5 InvaGen Pharmaceuticals Latest Developments
13.16 Alkem Laboratories
13.16.1 Alkem Laboratories Company Information
13.16.2 Alkem Laboratories Gabapentin Drug Product Portfolios and Specifications
13.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Alkem Laboratories Main Business Overview
13.16.5 Alkem Laboratories Latest Developments
13.17 Tris Pharma
13.17.1 Tris Pharma Company Information
13.17.2 Tris Pharma Gabapentin Drug Product Portfolios and Specifications
13.17.3 Tris Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Tris Pharma Main Business Overview
13.17.5 Tris Pharma Latest Developments
13.18 ACI HealthCare Limited
13.18.1 ACI HealthCare Limited Company Information
13.18.2 ACI HealthCare Limited Gabapentin Drug Product Portfolios and Specifications
13.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 ACI HealthCare Limited Main Business Overview
13.18.5 ACI HealthCare Limited Latest Developments
13.19 Jiangsu Hengrui Medicine
13.19.1 Jiangsu Hengrui Medicine Company Information
13.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolios and Specifications
13.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Jiangsu Hengrui Medicine Main Business Overview
13.19.5 Jiangsu Hengrui Medicine Latest Developments
13.20 CSPC Ouyi Pharmaceutical
13.20.1 CSPC Ouyi Pharmaceutical Company Information
13.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolios and Specifications
13.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 CSPC Ouyi Pharmaceutical Main Business Overview
13.20.5 CSPC Ouyi Pharmaceutical Latest Developments
13.21 Sciegen Pharmaceuticals
13.21.1 Sciegen Pharmaceuticals Company Information
13.21.2 Sciegen Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
13.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Sciegen Pharmaceuticals Main Business Overview
13.21.5 Sciegen Pharmaceuticals Latest Developments
13.22 Epic Pharma
13.22.1 Epic Pharma Company Information
13.22.2 Epic Pharma Gabapentin Drug Product Portfolios and Specifications
13.22.3 Epic Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Epic Pharma Main Business Overview
13.22.5 Epic Pharma Latest Developments
13.23 Lupin Limited
13.23.1 Lupin Limited Company Information
13.23.2 Lupin Limited Gabapentin Drug Product Portfolios and Specifications
13.23.3 Lupin Limited Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Lupin Limited Main Business Overview
13.23.5 Lupin Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gabapentin Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Gabapentin Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players ofTablet
Table 5. Major Players of Oral Solution
Table 6. Global Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 7. Global Gabapentin Drug Sales Market Share by Type (2020-2025)
Table 8. Global Gabapentin Drug Revenue by Type (2020-2025) & ($ million)
Table 9. Global Gabapentin Drug Revenue Market Share by Type (2020-2025)
Table 10. Global Gabapentin Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Gabapentin Drug Sale by Application (2020-2025) & (K Units)
Table 12. Global Gabapentin Drug Sale Market Share by Application (2020-2025)
Table 13. Global Gabapentin Drug Revenue by Application (2020-2025) & ($ million)
Table 14. Global Gabapentin Drug Revenue Market Share by Application (2020-2025)
Table 15. Global Gabapentin Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Gabapentin Drug Sales by Company (2020-2025) & (K Units)
Table 17. Global Gabapentin Drug Sales Market Share by Company (2020-2025)
Table 18. Global Gabapentin Drug Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Gabapentin Drug Revenue Market Share by Company (2020-2025)
Table 20. Global Gabapentin Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Gabapentin Drug Producing Area Distribution and Sales Area
Table 22. Players Gabapentin Drug Products Offered
Table 23. Gabapentin Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Gabapentin Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Gabapentin Drug Sales Market Share Geographic Region (2020-2025)
Table 28. Global Gabapentin Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Gabapentin Drug Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Gabapentin Drug Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Gabapentin Drug Sales Market Share by Country/Region (2020-2025)
Table 32. Global Gabapentin Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Gabapentin Drug Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Gabapentin Drug Sales by Country (2020-2025) & (K Units)
Table 35. Americas Gabapentin Drug Sales Market Share by Country (2020-2025)
Table 36. Americas Gabapentin Drug Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 38. Americas Gabapentin Drug Sales by Application (2020-2025) & (K Units)
Table 39. APAC Gabapentin Drug Sales by Region (2020-2025) & (K Units)
Table 40. APAC Gabapentin Drug Sales Market Share by Region (2020-2025)
Table 41. APAC Gabapentin Drug Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 43. APAC Gabapentin Drug Sales by Application (2020-2025) & (K Units)
Table 44. Europe Gabapentin Drug Sales by Country (2020-2025) & (K Units)
Table 45. Europe Gabapentin Drug Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 47. Europe Gabapentin Drug Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Gabapentin Drug Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Gabapentin Drug Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Gabapentin Drug Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Gabapentin Drug
Table 53. Key Market Challenges & Risks of Gabapentin Drug
Table 54. Key Industry Trends of Gabapentin Drug
Table 55. Gabapentin Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Gabapentin Drug Distributors List
Table 58. Gabapentin Drug Customer List
Table 59. Global Gabapentin Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Gabapentin Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Gabapentin Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Gabapentin Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Gabapentin Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Gabapentin Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Gabapentin Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Gabapentin Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Gabapentin Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Gabapentin Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Gabapentin Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Gabapentin Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Gabapentin Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Gabapentin Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Pfizer Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Gabapentin Drug Product Portfolios and Specifications
Table 75. Pfizer Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Depomed Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Depomed Gabapentin Drug Product Portfolios and Specifications
Table 80. Depomed Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Depomed Main Business
Table 82. Depomed Latest Developments
Table 83. Apotex Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Apotex Gabapentin Drug Product Portfolios and Specifications
Table 85. Apotex Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Apotex Main Business
Table 87. Apotex Latest Developments
Table 88. Teva Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Gabapentin Drug Product Portfolios and Specifications
Table 90. Teva Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Teva Main Business
Table 92. Teva Latest Developments
Table 93. Acella Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Acella Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 95. Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Acella Pharmaceuticals Main Business
Table 97. Acella Pharmaceuticals Latest Developments
Table 98. Taro Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Taro Gabapentin Drug Product Portfolios and Specifications
Table 100. Taro Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Taro Main Business
Table 102. Taro Latest Developments
Table 103. Sun Pharmaceutical Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Sun Pharmaceutical Gabapentin Drug Product Portfolios and Specifications
Table 105. Sun Pharmaceutical Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Sun Pharmaceutical Main Business
Table 107. Sun Pharmaceutical Latest Developments
Table 108. Glenmark Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Glenmark Gabapentin Drug Product Portfolios and Specifications
Table 110. Glenmark Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Glenmark Main Business
Table 112. Glenmark Latest Developments
Table 113. Amneal Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Amneal Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 115. Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Amneal Pharmaceuticals Main Business
Table 117. Amneal Pharmaceuticals Latest Developments
Table 118. Aurobindo Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Aurobindo Pharma Gabapentin Drug Product Portfolios and Specifications
Table 120. Aurobindo Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Aurobindo Pharma Main Business
Table 122. Aurobindo Pharma Latest Developments
Table 123. Zydus Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Zydus Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 125. Zydus Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Zydus Pharmaceuticals Main Business
Table 127. Zydus Pharmaceuticals Latest Developments
Table 128. Hi-Tech Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 130. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Hi-Tech Pharmaceuticals Main Business
Table 132. Hi-Tech Pharmaceuticals Latest Developments
Table 133. Marksans Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Marksans Pharma Gabapentin Drug Product Portfolios and Specifications
Table 135. Marksans Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Marksans Pharma Main Business
Table 137. Marksans Pharma Latest Developments
Table 138. Mylan Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. Mylan Gabapentin Drug Product Portfolios and Specifications
Table 140. Mylan Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Mylan Main Business
Table 142. Mylan Latest Developments
Table 143. InvaGen Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 144. InvaGen Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 145. InvaGen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. InvaGen Pharmaceuticals Main Business
Table 147. InvaGen Pharmaceuticals Latest Developments
Table 148. Alkem Laboratories Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 149. Alkem Laboratories Gabapentin Drug Product Portfolios and Specifications
Table 150. Alkem Laboratories Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 151. Alkem Laboratories Main Business
Table 152. Alkem Laboratories Latest Developments
Table 153. Tris Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 154. Tris Pharma Gabapentin Drug Product Portfolios and Specifications
Table 155. Tris Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 156. Tris Pharma Main Business
Table 157. Tris Pharma Latest Developments
Table 158. ACI HealthCare Limited Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 159. ACI HealthCare Limited Gabapentin Drug Product Portfolios and Specifications
Table 160. ACI HealthCare Limited Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 161. ACI HealthCare Limited Main Business
Table 162. ACI HealthCare Limited Latest Developments
Table 163. Jiangsu Hengrui Medicine Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 164. Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolios and Specifications
Table 165. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 166. Jiangsu Hengrui Medicine Main Business
Table 167. Jiangsu Hengrui Medicine Latest Developments
Table 168. CSPC Ouyi Pharmaceutical Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 169. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolios and Specifications
Table 170. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 171. CSPC Ouyi Pharmaceutical Main Business
Table 172. CSPC Ouyi Pharmaceutical Latest Developments
Table 173. Sciegen Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 174. Sciegen Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 175. Sciegen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 176. Sciegen Pharmaceuticals Main Business
Table 177. Sciegen Pharmaceuticals Latest Developments
Table 178. Epic Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 179. Epic Pharma Gabapentin Drug Product Portfolios and Specifications
Table 180. Epic Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 181. Epic Pharma Main Business
Table 182. Epic Pharma Latest Developments
Table 183. Lupin Limited Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 184. Lupin Limited Gabapentin Drug Product Portfolios and Specifications
Table 185. Lupin Limited Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 186. Lupin Limited Main Business
Table 187. Lupin Limited Latest Developments
Table 1. Gabapentin Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Gabapentin Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players ofTablet
Table 5. Major Players of Oral Solution
Table 6. Global Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 7. Global Gabapentin Drug Sales Market Share by Type (2020-2025)
Table 8. Global Gabapentin Drug Revenue by Type (2020-2025) & ($ million)
Table 9. Global Gabapentin Drug Revenue Market Share by Type (2020-2025)
Table 10. Global Gabapentin Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Gabapentin Drug Sale by Application (2020-2025) & (K Units)
Table 12. Global Gabapentin Drug Sale Market Share by Application (2020-2025)
Table 13. Global Gabapentin Drug Revenue by Application (2020-2025) & ($ million)
Table 14. Global Gabapentin Drug Revenue Market Share by Application (2020-2025)
Table 15. Global Gabapentin Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Gabapentin Drug Sales by Company (2020-2025) & (K Units)
Table 17. Global Gabapentin Drug Sales Market Share by Company (2020-2025)
Table 18. Global Gabapentin Drug Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Gabapentin Drug Revenue Market Share by Company (2020-2025)
Table 20. Global Gabapentin Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Gabapentin Drug Producing Area Distribution and Sales Area
Table 22. Players Gabapentin Drug Products Offered
Table 23. Gabapentin Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Gabapentin Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Gabapentin Drug Sales Market Share Geographic Region (2020-2025)
Table 28. Global Gabapentin Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Gabapentin Drug Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Gabapentin Drug Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Gabapentin Drug Sales Market Share by Country/Region (2020-2025)
Table 32. Global Gabapentin Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Gabapentin Drug Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Gabapentin Drug Sales by Country (2020-2025) & (K Units)
Table 35. Americas Gabapentin Drug Sales Market Share by Country (2020-2025)
Table 36. Americas Gabapentin Drug Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 38. Americas Gabapentin Drug Sales by Application (2020-2025) & (K Units)
Table 39. APAC Gabapentin Drug Sales by Region (2020-2025) & (K Units)
Table 40. APAC Gabapentin Drug Sales Market Share by Region (2020-2025)
Table 41. APAC Gabapentin Drug Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 43. APAC Gabapentin Drug Sales by Application (2020-2025) & (K Units)
Table 44. Europe Gabapentin Drug Sales by Country (2020-2025) & (K Units)
Table 45. Europe Gabapentin Drug Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 47. Europe Gabapentin Drug Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Gabapentin Drug Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Gabapentin Drug Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Gabapentin Drug Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Gabapentin Drug Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Gabapentin Drug
Table 53. Key Market Challenges & Risks of Gabapentin Drug
Table 54. Key Industry Trends of Gabapentin Drug
Table 55. Gabapentin Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Gabapentin Drug Distributors List
Table 58. Gabapentin Drug Customer List
Table 59. Global Gabapentin Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Gabapentin Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Gabapentin Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Gabapentin Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Gabapentin Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Gabapentin Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Gabapentin Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Gabapentin Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Gabapentin Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Gabapentin Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Gabapentin Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Gabapentin Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Gabapentin Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Gabapentin Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Pfizer Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Gabapentin Drug Product Portfolios and Specifications
Table 75. Pfizer Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Depomed Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Depomed Gabapentin Drug Product Portfolios and Specifications
Table 80. Depomed Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Depomed Main Business
Table 82. Depomed Latest Developments
Table 83. Apotex Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Apotex Gabapentin Drug Product Portfolios and Specifications
Table 85. Apotex Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Apotex Main Business
Table 87. Apotex Latest Developments
Table 88. Teva Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Gabapentin Drug Product Portfolios and Specifications
Table 90. Teva Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Teva Main Business
Table 92. Teva Latest Developments
Table 93. Acella Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Acella Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 95. Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Acella Pharmaceuticals Main Business
Table 97. Acella Pharmaceuticals Latest Developments
Table 98. Taro Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Taro Gabapentin Drug Product Portfolios and Specifications
Table 100. Taro Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Taro Main Business
Table 102. Taro Latest Developments
Table 103. Sun Pharmaceutical Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Sun Pharmaceutical Gabapentin Drug Product Portfolios and Specifications
Table 105. Sun Pharmaceutical Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Sun Pharmaceutical Main Business
Table 107. Sun Pharmaceutical Latest Developments
Table 108. Glenmark Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Glenmark Gabapentin Drug Product Portfolios and Specifications
Table 110. Glenmark Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Glenmark Main Business
Table 112. Glenmark Latest Developments
Table 113. Amneal Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Amneal Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 115. Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Amneal Pharmaceuticals Main Business
Table 117. Amneal Pharmaceuticals Latest Developments
Table 118. Aurobindo Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Aurobindo Pharma Gabapentin Drug Product Portfolios and Specifications
Table 120. Aurobindo Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Aurobindo Pharma Main Business
Table 122. Aurobindo Pharma Latest Developments
Table 123. Zydus Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Zydus Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 125. Zydus Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Zydus Pharmaceuticals Main Business
Table 127. Zydus Pharmaceuticals Latest Developments
Table 128. Hi-Tech Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 130. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Hi-Tech Pharmaceuticals Main Business
Table 132. Hi-Tech Pharmaceuticals Latest Developments
Table 133. Marksans Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Marksans Pharma Gabapentin Drug Product Portfolios and Specifications
Table 135. Marksans Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Marksans Pharma Main Business
Table 137. Marksans Pharma Latest Developments
Table 138. Mylan Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. Mylan Gabapentin Drug Product Portfolios and Specifications
Table 140. Mylan Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Mylan Main Business
Table 142. Mylan Latest Developments
Table 143. InvaGen Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 144. InvaGen Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 145. InvaGen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. InvaGen Pharmaceuticals Main Business
Table 147. InvaGen Pharmaceuticals Latest Developments
Table 148. Alkem Laboratories Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 149. Alkem Laboratories Gabapentin Drug Product Portfolios and Specifications
Table 150. Alkem Laboratories Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 151. Alkem Laboratories Main Business
Table 152. Alkem Laboratories Latest Developments
Table 153. Tris Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 154. Tris Pharma Gabapentin Drug Product Portfolios and Specifications
Table 155. Tris Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 156. Tris Pharma Main Business
Table 157. Tris Pharma Latest Developments
Table 158. ACI HealthCare Limited Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 159. ACI HealthCare Limited Gabapentin Drug Product Portfolios and Specifications
Table 160. ACI HealthCare Limited Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 161. ACI HealthCare Limited Main Business
Table 162. ACI HealthCare Limited Latest Developments
Table 163. Jiangsu Hengrui Medicine Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 164. Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolios and Specifications
Table 165. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 166. Jiangsu Hengrui Medicine Main Business
Table 167. Jiangsu Hengrui Medicine Latest Developments
Table 168. CSPC Ouyi Pharmaceutical Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 169. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolios and Specifications
Table 170. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 171. CSPC Ouyi Pharmaceutical Main Business
Table 172. CSPC Ouyi Pharmaceutical Latest Developments
Table 173. Sciegen Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 174. Sciegen Pharmaceuticals Gabapentin Drug Product Portfolios and Specifications
Table 175. Sciegen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 176. Sciegen Pharmaceuticals Main Business
Table 177. Sciegen Pharmaceuticals Latest Developments
Table 178. Epic Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 179. Epic Pharma Gabapentin Drug Product Portfolios and Specifications
Table 180. Epic Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 181. Epic Pharma Main Business
Table 182. Epic Pharma Latest Developments
Table 183. Lupin Limited Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors
Table 184. Lupin Limited Gabapentin Drug Product Portfolios and Specifications
Table 185. Lupin Limited Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 186. Lupin Limited Main Business
Table 187. Lupin Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Gabapentin Drug
Figure 2. Gabapentin Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gabapentin Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Gabapentin Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Gabapentin Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Gabapentin Drug Sales Market Share by Country/Region (2024)
Figure 10. Gabapentin Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Capsule
Figure 12. Product Picture ofTablet
Figure 13. Product Picture of Oral Solution
Figure 14. Global Gabapentin Drug Sales Market Share by Type in 2025
Figure 15. Global Gabapentin Drug Revenue Market Share by Type (2020-2025)
Figure 16. Gabapentin Drug Consumed in Postherpetic Neuralgia in Adults
Figure 17. Global Gabapentin Drug Market: Postherpetic Neuralgia in Adults (2020-2025) & (K Units)
Figure 18. Gabapentin Drug Consumed in Partial Onset Seizures
Figure 19. Global Gabapentin Drug Market: Partial Onset Seizures (2020-2025) & (K Units)
Figure 20. Gabapentin Drug Consumed in Others
Figure 21. Global Gabapentin Drug Market: Others (2020-2025) & (K Units)
Figure 22. Global Gabapentin Drug Sale Market Share by Application (2024)
Figure 23. Global Gabapentin Drug Revenue Market Share by Application in 2025
Figure 24. Gabapentin Drug Sales by Company in 2025 (K Units)
Figure 25. Global Gabapentin Drug Sales Market Share by Company in 2025
Figure 26. Gabapentin Drug Revenue by Company in 2025 ($ millions)
Figure 27. Global Gabapentin Drug Revenue Market Share by Company in 2025
Figure 28. Global Gabapentin Drug Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Gabapentin Drug Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Gabapentin Drug Sales 2020-2025 (K Units)
Figure 31. Americas Gabapentin Drug Revenue 2020-2025 ($ millions)
Figure 32. APAC Gabapentin Drug Sales 2020-2025 (K Units)
Figure 33. APAC Gabapentin Drug Revenue 2020-2025 ($ millions)
Figure 34. Europe Gabapentin Drug Sales 2020-2025 (K Units)
Figure 35. Europe Gabapentin Drug Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Gabapentin Drug Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Gabapentin Drug Revenue 2020-2025 ($ millions)
Figure 38. Americas Gabapentin Drug Sales Market Share by Country in 2025
Figure 39. Americas Gabapentin Drug Revenue Market Share by Country (2020-2025)
Figure 40. Americas Gabapentin Drug Sales Market Share by Type (2020-2025)
Figure 41. Americas Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 42. United States Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Gabapentin Drug Sales Market Share by Region in 2025
Figure 47. APAC Gabapentin Drug Revenue Market Share by Region (2020-2025)
Figure 48. APAC Gabapentin Drug Sales Market Share by Type (2020-2025)
Figure 49. APAC Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 50. China Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. India Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Gabapentin Drug Sales Market Share by Country in 2025
Figure 58. Europe Gabapentin Drug Revenue Market Share by Country (2020-2025)
Figure 59. Europe Gabapentin Drug Sales Market Share by Type (2020-2025)
Figure 60. Europe Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 61. Germany Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. France Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Gabapentin Drug Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Gabapentin Drug Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 69. Egypt Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Gabapentin Drug in 2025
Figure 75. Manufacturing Process Analysis of Gabapentin Drug
Figure 76. Industry Chain Structure of Gabapentin Drug
Figure 77. Channels of Distribution
Figure 78. Global Gabapentin Drug Sales Market Forecast by Region (2026-2031)
Figure 79. Global Gabapentin Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Gabapentin Drug Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Gabapentin Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Gabapentin Drug Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Gabapentin Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Gabapentin Drug
Figure 2. Gabapentin Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gabapentin Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Gabapentin Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Gabapentin Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Gabapentin Drug Sales Market Share by Country/Region (2024)
Figure 10. Gabapentin Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Capsule
Figure 12. Product Picture ofTablet
Figure 13. Product Picture of Oral Solution
Figure 14. Global Gabapentin Drug Sales Market Share by Type in 2025
Figure 15. Global Gabapentin Drug Revenue Market Share by Type (2020-2025)
Figure 16. Gabapentin Drug Consumed in Postherpetic Neuralgia in Adults
Figure 17. Global Gabapentin Drug Market: Postherpetic Neuralgia in Adults (2020-2025) & (K Units)
Figure 18. Gabapentin Drug Consumed in Partial Onset Seizures
Figure 19. Global Gabapentin Drug Market: Partial Onset Seizures (2020-2025) & (K Units)
Figure 20. Gabapentin Drug Consumed in Others
Figure 21. Global Gabapentin Drug Market: Others (2020-2025) & (K Units)
Figure 22. Global Gabapentin Drug Sale Market Share by Application (2024)
Figure 23. Global Gabapentin Drug Revenue Market Share by Application in 2025
Figure 24. Gabapentin Drug Sales by Company in 2025 (K Units)
Figure 25. Global Gabapentin Drug Sales Market Share by Company in 2025
Figure 26. Gabapentin Drug Revenue by Company in 2025 ($ millions)
Figure 27. Global Gabapentin Drug Revenue Market Share by Company in 2025
Figure 28. Global Gabapentin Drug Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Gabapentin Drug Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Gabapentin Drug Sales 2020-2025 (K Units)
Figure 31. Americas Gabapentin Drug Revenue 2020-2025 ($ millions)
Figure 32. APAC Gabapentin Drug Sales 2020-2025 (K Units)
Figure 33. APAC Gabapentin Drug Revenue 2020-2025 ($ millions)
Figure 34. Europe Gabapentin Drug Sales 2020-2025 (K Units)
Figure 35. Europe Gabapentin Drug Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Gabapentin Drug Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Gabapentin Drug Revenue 2020-2025 ($ millions)
Figure 38. Americas Gabapentin Drug Sales Market Share by Country in 2025
Figure 39. Americas Gabapentin Drug Revenue Market Share by Country (2020-2025)
Figure 40. Americas Gabapentin Drug Sales Market Share by Type (2020-2025)
Figure 41. Americas Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 42. United States Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Gabapentin Drug Sales Market Share by Region in 2025
Figure 47. APAC Gabapentin Drug Revenue Market Share by Region (2020-2025)
Figure 48. APAC Gabapentin Drug Sales Market Share by Type (2020-2025)
Figure 49. APAC Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 50. China Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. India Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Gabapentin Drug Sales Market Share by Country in 2025
Figure 58. Europe Gabapentin Drug Revenue Market Share by Country (2020-2025)
Figure 59. Europe Gabapentin Drug Sales Market Share by Type (2020-2025)
Figure 60. Europe Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 61. Germany Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. France Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Gabapentin Drug Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Gabapentin Drug Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Gabapentin Drug Sales Market Share by Application (2020-2025)
Figure 69. Egypt Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Gabapentin Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Gabapentin Drug in 2025
Figure 75. Manufacturing Process Analysis of Gabapentin Drug
Figure 76. Industry Chain Structure of Gabapentin Drug
Figure 77. Channels of Distribution
Figure 78. Global Gabapentin Drug Sales Market Forecast by Region (2026-2031)
Figure 79. Global Gabapentin Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Gabapentin Drug Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Gabapentin Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Gabapentin Drug Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Gabapentin Drug Revenue Market Share Forecast by Application (2026-2031)
